tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Naureen Quibria, 13 are a BUY (92.86%), 1 are a HOLD (7.14%).
Analyst Naureen Quibria, currently employed at CAPITAL ONE,
Naureen Quibria’s has documented 25 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IMMP, Immutep Ltd ADR at 17-May-2024.
Analyst best performing recommendations are on ONCR (ONCORUS ).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$10
$7.12 (247.22%)
$7
4 months 15 days ago
(13-Dec-2024)
1/6 (16.67%)
$6.08 (155.10%)
547
Buy
$13
$10.12 (351.39%)
$14
5 months 20 days ago
(08-Nov-2024)
0/5 (0%)
$9.92 (322.08%)
Buy
$5
$2.12 (73.61%)
$6
2 years 7 months 1 days ago
(27-Sep-2022)
1/3 (33.33%)
$3.45 (222.58%)
533
Buy
$25
$23.61 (1698.56%)
3 years 7 months 20 days ago
(09-Sep-2021)
0/1 (0%)
$18.01 (257.65%)
What Year was the first public recommendation made by Naureen Quibria?
